Replies to post #112860 on Biotech Values

[pcrutch]

Of the 3 potential outcomes you listed below, what probability or chance are you toying with for each outcome? What kind of price ranges are you modeling for these scenarios?

My take

The first outcome is clearly the most beneficial to their share price; mid$20's would be back in play.

Second outcome would be beneficial, but most investors might not understand the significance. (maybe high teens, depending on how the media spins it )

3rd outcome would be a major problem. ($10-12)